These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24132234)

  • 1. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
    Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
    Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
    Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
    Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
    Yoshida-Moriguchi T; Campbell KP
    Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
    Balci-Hayta B; Talim B; Kale G; Dincer P
    BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystroglycan glycosylation and muscular dystrophy.
    Moore CJ; Hewitt JE
    Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.
    Gumerson JD; Davis CS; Kabaeva ZT; Hayes JM; Brooks SV; Michele DE
    Hum Mol Genet; 2013 Feb; 22(4):757-68. PubMed ID: 23222475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
    Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
    Elife; 2023 Feb; 12():. PubMed ID: 36723429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.
    Willer T; Inamori K; Venzke D; Harvey C; Morgensen G; Hara Y; Beltrán Valero de Bernabé D; Yu L; Wright KM; Campbell KP
    Elife; 2014 Oct; 3():. PubMed ID: 25279699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
    Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
    FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
    Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
    Jayasinha V; Nguyen HH; Xia B; Kammesheidt A; Hoyte K; Martin PT
    Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
    Zhang P; Yang Y; Candiello J; Thorn TL; Gray N; Halfter WM; Hu H
    Matrix Biol; 2013 Apr; 32(3-4):196-207. PubMed ID: 23454088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle.
    Brockington M; Torelli S; Sharp PS; Liu K; Cirak S; Brown SC; Wells DJ; Muntoni F
    PLoS One; 2010 Dec; 5(12):e14434. PubMed ID: 21203384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.